Next-gen TCR-based therapies against solid tumors have the power to disrupt and transform the development, delivery, and efficacy for cancer patients. Dan Macleod, ImmunoScape’s SVP of Discovery, will be an expert speaker at this year’s TCR-based Therapies for Solid Tumors Summit in Boston. We look forward to joining the impressive line-up of innovators accelerating the development of TCR-based therapies against solid tumors.
Please join Dan’s talk if you’re attending this year’s summit! Check out the full agenda: https://lnkd.in/gF2zkg8